| abstract |
The present invention relates to novel peptides whose individual components are L-amino acids or D-amino acids. The peptide is for treating diseases in which increased incidence of free radicals plays a pathophysiological role, or for treating diseases associated with acute hypoxia or ischemia in the body organ system, particularly the central nervous system, Or to treat iron storage diseases, such as Hallervorden-Spatz syndrome, or neurodegenerative diseases, in particular Alzheimer's disease, Lewy bodily variants of Alzheimer's disease, Parkinson's disease, multiple system atrophy, Lewy body dementia or Huntington's chorea, and the nerve Used as an active ingredient in drugs to treat all syndromes similar to degenerative diseases. |